Top Markets
Coin of the day
Arctic Bioscience AS Arctic Bioscience AS

Arctic Bioscience AS

ABS
Classement en actions #33046
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Prix de l'action
$0.3144463
Capitalisation boursière
$8.48M
Changement (1 jour)
0.00%
Changement (1 an)
-2.55%
Pays
NO
Échange Arctic Bioscience AS (ABS)

Catégorie

Historique du rendement du dividende pour Arctic Bioscience AS (ABS)
Le rendement du dividende (TTM) de Arctic Bioscience AS (symbole boursier : ABS) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Arctic Bioscience AS (ABS) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.48%
BE